Contents
The ACS Spectrum
- Unstable angina: ischemia, NO troponin rise
- NSTEMI: troponin rise WITHOUT ST elevation (often ST depression/T inversion)
- STEMI: troponin rise WITH ST elevation — full-thickness, time-critical
- All represent acute myocardial ischemia from plaque rupture and thrombus
Pathophysiology
- Atherosclerotic plaque ruptures → platelet aggregation → coronary thrombus
- Partial occlusion = UA/NSTEMI; complete occlusion = STEMI
- Ischemia → injury → infarction if flow is not restored
- "Time is muscle" — reperfusion speed determines outcome
Presentation
- Chest pressure/pain, often radiating to arm/jaw, with diaphoresis, dyspnea, nausea
- Atypical presentations in women, elderly, and diabetics (fatigue, SOB)
- Get a 12-lead ECG within 10 minutes of arrival
- Assess for hemodynamic instability and arrhythmia
ECG Localization
- Inferior: II, III, aVF (right coronary artery)
- Anterior/septal: V1–V4 (LAD)
- Lateral: I, aVL, V5–V6 (circumflex)
- Inferior MI: get a right-sided ECG — RV involvement makes nitro dangerous (preload-dependent)
Cardiac Biomarkers
- Troponin is the most specific marker; rises 3–6 hr, peaks ~12–24 hr
- Serial troponins establish the trend
- A normal troponin does not exclude unstable angina
- Correlate biomarkers with ECG and symptoms
Initial Management
- Aspirin (chewed) early unless contraindicated
- Antiplatelet (P2Y₁₂ inhibitor) + anticoagulation per protocol
- Nitroglycerin for pain/ischemia — AVOID in RV infarct, hypotension, or recent PDE-5 inhibitor use
- Oxygen only if SpO₂ <90%; morphine for refractory pain; statin
Reperfusion Strategy
- STEMI: emergent PCI is preferred — door-to-balloon ≤90 min
- If PCI unavailable in time: fibrinolytics within 30 min (door-to-needle), if no contraindications
- NSTEMI/UA: risk-stratify; early invasive (angiography) for high risk
- Know absolute fibrinolytic contraindications (prior ICH, active bleeding, recent stroke, etc.)
Post-MI Complications
- Arrhythmias: VTach/VFib (leading early cause of death), heart block (esp. inferior MI)
- Cardiogenic shock: large infarct → pump failure
- Mechanical: papillary muscle rupture (acute MR), VSD, free-wall rupture
- Heart failure, pericarditis (Dressler), reinfarction
Key Medications (longer term)
- Dual antiplatelet therapy (aspirin + P2Y₁₂ inhibitor)
- Beta-blocker (reduces myocardial O₂ demand) unless contraindicated
- ACE inhibitor and high-intensity statin
- Anticoagulation during the acute phase per protocol
Nursing Priorities
- Continuous ECG monitoring; treat arrhythmias promptly
- Serial troponins, pain assessment, and hemodynamic monitoring
- Prepare for cath lab; minimize door-to-balloon time
- Patient education: medication adherence, risk-factor modification, cardiac rehab
Can you answer these 3 CCRN questions?
Here are 3 questions in the style of our premium bank. The full rationale explains exactly why the right answer is right — and why the distractors trap most test-takers.
A patient with an inferior STEMI (II, III, aVF) becomes hypotensive after sublingual nitroglycerin. The most likely explanation is:
- Anaphylaxis to nitroglycerin
- Right ventricular infarction with preload dependence
- Pulmonary embolism
- Aortic dissection
A patient arrives with a STEMI to a PCI-capable center. The priority goal is:
- Door-to-needle time under 30 minutes
- Door-to-balloon time under 90 minutes
- Administer fibrinolytics immediately
- Obtain serial troponins before any treatment
Which ECG leads correspond to an anterior wall MI?
- II, III, aVF
- V1–V4
- I, aVL, V5–V6
- V7–V9
Related CCRN Guides
Frequently Asked Questions
What is the difference between unstable angina, NSTEMI, and STEMI?
What is the goal door-to-balloon time for STEMI?
Why is nitroglycerin dangerous in an inferior or right ventricular MI?
How is the location of an MI identified on ECG?
What is the most common cause of early death after an MI?
Want the full CCRN experience?
Practice with 695+ exam-style questions, adaptive flashcards, and AI-powered weak-area drilling inside the Zero Deficit app.
Start Free →